1222107

Abbvie Biotechnology Ltd. — FEI 3004620772

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 30, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barceloneta, PR (United States)